Pot Still a Drug of Choice for Many U.S. Adults
4:00 PM CDT.
Read article
- Could Herpes Virus Play a Role in Alzheimer’s?
- 2.5 Million U.S. High School Students Had a Concussion in Past Year
- Massive Study Finds Same Genes Drive Many Psychiatric Conditions
- AHA: Take Your Dog to Work—And Reap the Health Benefits
JOURNAL UPDATE
Medicaid Expansion Ups Preemptive Listing for Kidney Transplant
7:00 PM CDT. From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive…- BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes
- Many Physicians Not Prepared for End-of-Life Talks With Patients
- More Cash-Pay Patients Means Docs Need Billing Strategies
MONTHLY JOURNAL SUMMARY
May 2018 Briefing - Pharmacy
June 01, 2018. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
MEDICAL FOCUS
Alzheimer’s disease
By Tamer M. Fouad, M.D.Alzheimer’s disease (AD) is the most common cause of dementia in Western countries.
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By MrRobinGreat articles. learnt a lot from it.
ANNOUNCEMENTS
Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.
